Catalyst Brief

← Calendar

Readoutin 44d

Novartis Pharmaceuticals — Placebo

Phase 3 primary completion: Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes.

Date
Jan 2027
Type
Readout
Indication
Acute Coronary Syndrome

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Novartis Pharmaceuticals

  1. May2027
  2. May2027
  3. Apr2027
  4. Mar2027
  5. Feb2027